Table. Patient Characteristics.
| Characteristic | No. (%) |
|---|---|
| Sex | |
| Female | 361 (43.8) |
| Male | 463 (56.2) |
| Age at diagnosis of neoplasm, y | |
| 0-5 | 368 (44.7) |
| 6-10 | 146 (17.7) |
| 11-15 | 216 (26.2) |
| 16-18 | 94 (11.4) |
| Diagnosis | |
| Hematologic neoplasms | 335 (40.7) |
| Acute lymphoblastic leukemia | 175 (21.2) |
| Hodgkin lymphoma | 64 (7.8) |
| Non-Hodgkin lymphoma | 42 (5.1) |
| AML/CML/other myeloid leukemia | 41 (5.0) |
| Myelodysplastic syndrome/aplastic anemia | 10 (1.2) |
| Other | 3 (0.4) |
| Non-CNS solid tumors | 309 (37.5) |
| Neuroblastoma | 47 (5.7) |
| Wilms tumor | 43 (5.2) |
| Osteosarcoma | 34 (4.1) |
| Rhabdomyosarcoma | 32 (3.9) |
| Germcell tumor | 35 (4.2) |
| Ewing (like) sarcoma | 27 (3.3) |
| Fibrosarcomas and other fibrous neoplasms | 16 (1.9) |
| Retinoblastoma | 14 (1.7) |
| Sarcoma other | 10 (1.2) |
| Liver tumor | 9 (1.1) |
| Melanoma | 7 (0.8) |
| Kidney tumor other than Wilms tumor | 7 (0.8) |
| Extra kidney rhabdoid tumor | 4 (0.5) |
| Other | 24 (2.9) |
| CNS tumors | 180 (21.8) |
| Low-grade glioma, WHO grade 1-2 | 78 (9.5) |
| High-grade glioma, WHO grade 3-4 | 28 (3.4) |
| Medulloblastoma | 29 (3.5) |
| Ependymoma | 14 (1.7) |
| Germcell tumor | 12 (1.5) |
| Craniopharyngioma | 6 (0.7) |
| Rhabdoid tumor | 3 (0.4) |
| Schwannoma | 3 (0.4) |
| Other | 7 (0.8) |
Abbreviations: AML, acute myeloid leukemia; CML, chronic myeloid leukemia; CNS, central nervous system; WHO, World Health Organization.